PDF herunterladen
Thromb Haemost 1974; 32(01): 057-064
DOI: 10.1055/s-0038-1647672
Original Article
Schattauer GmbH

Self-Damping Mechanism in Blood Coagulation[*]

Y Nemerson
1   Department of Internal Medicine, Yale University, New Haven, Connecticut 06510
,
S.A Silverberg
1   Department of Internal Medicine, Yale University, New Haven, Connecticut 06510
,
J Jesty
1   Department of Internal Medicine, Yale University, New Haven, Connecticut 06510
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 16. August 1974

Accepted after resubmission 16. August 1974

Publikationsdatum:
30. Juni 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

Two reactions of the extrinsic pathway of coagulation, the activations of Factor X and prothrombin, have been studied in purified systems and shown to be self-damping. Factor X was activated by the tissue factor - Factor VII complex, and prothrombin by two systems: the coagulant protein of Taipan venom, and the physiological complex of activated Factor X, Factor V, lipid, and calcium ions. In each case the yield of enzyme, activated Factor X or thrombin, is a function of the concentration of activator. These and other observations are considered as a basis for a control mechanism in coagulation.

* Presented at the Symposium on Thrombosis, American Society of Hematology Meeting in Chicago, December 1973.


 

  • References

  • 1 Davie E. W, Ratnoff O. D. 1964; Waterfall sequence for intrinsic’blood clotting. Science 145: 1310.
    CrossrefPubMedGoogle Scholar
  • 2 Denson K. W. E, Borrett R, Biggs R. 1971; The specific assay of prothrombin using the Taipan snake venom. British Journal of Haematology 21: 219.
    CrossrefPubMedGoogle Scholar
  • 3 Esnouf M. P, Lloyd P. H, Jesty J. 1973; A method for the simultaneous isolation of Factor X and prothrombin from bovine plasma. Biochemical Journal 131: 781.
    CrossrefPubMedGoogle Scholar
  • 4 Fairbanks G, Steck T. L, Wallach D. F. H. 1971; Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10: 2606.
    CrossrefPubMedGoogle Scholar
  • 5 Gitel S. N, Owen W. G, Esmon C. T, Jackson C. M. 1973; A polypeptide region of bovine prothrombin specific for binding to phospholipids. Proceedings of the National Academy of Sciences of the U.S.A 70: 1344.
    CrossrefPubMedGoogle Scholar
  • 6 Heldebrandt C. M, Butkowski R. J, Bajaj S. P, Mann K. G. 1973; The activation of prothrombin. Journal of Biological Chemistry 248: 7149.
    PubMedGoogle Scholar
  • 7 Jesty J, Esnouf M. P. 1973; The preparation of activated Factor X and its action on prothrombin. Biochemical Journal 131: 791.
    CrossrefPubMedGoogle Scholar
  • 8 Jesty J, Nemerson Y. 1974; Purification of Factor VII from bovine plasma. Journal of Biological Chemistry 249: 509.
    PubMedGoogle Scholar
  • 9 Jesty J, Sbencer A. K, Nemerson Y. 1974; The mechanism of activation of Factor X. Journal of Biological Chemistry 249: 5614.
    PubMedGoogle Scholar
  • 10 Jobin F, Esnouf M. P. 1967; Studies on the formation of the prothrombinconverting complex. Biochemical Journal 102: 666.
    CrossrefPubMedGoogle Scholar
  • 11 Lanchantin G. F, Friedman J. A, Hart D. W. 1973; Two forms of human thrombin. Journal of Biological Chemistry 248: 5956.
    PubMedGoogle Scholar
  • 12 Macfarlane R. G. 1964; An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 202: 498.
    CrossrefPubMedGoogle Scholar
  • 13 Marciniak E. 1970; Functional and steric characteristics of modified thrombin zymogen. Thrombosis et Diathesis Haemorrhagica 24: 361.
    PubMedGoogle Scholar
  • 14 Marciniak E, Seegers W. H. 1966; Prethrombin as a new sub-unit of prothrombin. Nature 209: 621.
    CrossrefPubMedGoogle Scholar
  • 15 Mertz E. T, Seegers W. H, Smith H. P. (1939 a) Inactivation of prothrombin by purified thrombin solutions. Proceedings of the Society for Experimental Biology and Medicine. 41: 657.
    PubMedGoogle Scholar
  • 16 Mertz E. T, Seegers W. H, Smith H. P. (1939b) Prothrombin, thromboplastin, and thrombin: quantitative interrelationships. Proceedings of the Society for Experimental Biology and Medicine 42: 604.
    PubMedGoogle Scholar
  • 17 Nemerson Y, Pitlick F. A. 1970; Purification and characterization of the protein component of tissue factor. Biochemistry 09: 5100.
    CrossrefPubMedGoogle Scholar
  • 18 Radcliffe R. D, Nemerson Y. 1974 Activation and control of Factor VII by activated Factor X and thrombin. Journal of Biological Chemistry. in press..
    PubMedGoogle Scholar
  • 19 Rapaport S. I, Schiffman S, Patch M. J, Ames S. B. 1963; The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. Blood 21: 221.
    PubMedGoogle Scholar
  • 20 Rosenberg R. D, Damus P. S. 1973; The purification and mechanism of action of human antithrombin-heparin cofactor. Journal of Biological Chemistry 248: 6490.
    PubMedGoogle Scholar
  • 21 Shulman N. R, Hearon J. Z. 1963; Kinetics of conversion of prothrombin to thrombin by biological activators. Journal of Biological Chemistry 238: 155.
    PubMedGoogle Scholar
  • 22 Stenflo J. 1973; Vitamin K and the biosynthesis of prothrombin. Journal of Biological Chemistry 248: 6325.
    PubMedGoogle Scholar
  • 23 Stenn K. S, Blotjt E. R. 1972; Mechanism of bovine prothrombin activation by an insoluble preparation of bovine Factor Xa (thrombokinase). Biochemistry 11: 4502.
    CrossrefPubMedGoogle Scholar
  • 24 Yin E. T, Wessler S, Stoll P. J. 1971; Biological properties of the naturally occurring plasma inhibitor of activated Factor X. Journal of Biological Chemistry 246: 3703.
    PubMedGoogle Scholar